ArticleBlood advances2026
Understanding the impact of social determinants of health in hematology: a scoping review of trends across journals and over time.
Article in Blood advances, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
abstractAddressing social determinants of health is increasingly recognized as a critical priority in medicine to optimize care delivery to all patients. To support health care providers, researchers, and the hematology field to process and synthesize the rapidly expanding hematology social determinants of health literature, we conducted a scoping review to catalog/describe recent hematology social determinants studies. Our goals were to highlight state of the art in hematology social determinants research, describe trends in this literature across journals/conferences and over time, identify gaps, and inspire efforts to improve health across populations. Our search returned 602 hematology articles and 153 abstracts. Most works examined racial or socioeconomic disparities among adults with hematologic malignancies or who are hematopoietic cell transplant/cell therapy recipients. In contrast, few explored basic science correlates of disparities, approaches to optimize collection, recording, reporting, and use of social determinants of health data, or interventions/educational initiatives to address care inequities. Many vulnerable populations were understudied, including Indigenous peoples; people living with disabilities; transgender/gender-nonbinary peoples; and disparities across parity, religion, or immigration/legal status. Only a minority of works considered intersectionality across multiple dimensions of disparities. Although both the number and proportion of social determinants studies increased over time, there were imbalances in journals in which these studies were published. Overall, this review is an important tool to advance hematology population health, highlight hematology social determinants of health research productivity, inform development of research agendas and priorities for societies/funders, and support researchers to address identified gaps. Closing these gaps will be essential to improve delivery of safe and effective hematologic care for all.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.